Next RHAC meeting (April, 2001)
- Tentative travel on 4/8/01; meeting all day 4/9/01
- Mary Lambert (Tel. # 202-205-1848) to be notified; she will need to inform VSO's regarding meeting date and time
- Agenda items proposed
- Response to Dr. Gough's request, letter of 12/5/00
- Science presentations
- Proposal reviews (4)
- Proposal review process
- Reviews are to be done according to the NIH-style review
- Two experts drawn from the RHAC or outside reviewers will assess each proposal
- Mechanism to improve documentation of meeting minutes (see page 1, above, "Reporting of future meeting minutes")
- Meeting (2 days) to be scheduled for September 2001; calendar to be circulated via email for scheduling (week of 9/10 Dr. Michalek not available)
- AF science presentation to address publications and research projects
- VA presentation to provide update on the Chemical Corps study (tentative); Han Kang to be contacted
- Create a public WebPage for RHAC and link to VA organizations and appropriate search engines.
- Question individuals regarding exposure to chemicals in the home (Dr. Favata)
- RFP is currently scheduled to be announced March 2, 2001; therefore need quick turn-around of SOW, highlighting changes noted at this RHAC meeting (Dr. Michalek)
- Need for guidance regarding ethical issues:
- Request appearance of expert (e.g. legal counsel) to discuss the ethics issues.
- Can we ethically use the samples?
- Can we find resources to support proper use of the samples?
- RHAC to contact the VA through Secretary HHS
- Discuss with National Academy of Sciences (NAS) the practical and ethical issues.
- Mr. Gary Kayajanian of Arlington, VA, shared data comparisons between Ranch Handers and controls. (A full reporting of his information is available in the verbatim transcript).
- Mr. Rick Weidman, representing Vietnam Veterans of America, offered comments. He indicated that he was meeting with Tommy Thompson, Secretary of HHS, this week and would be recommending that (a) the RHAC effort receive better overall and financial support, or (b) the stewardship of the RHAC project be dissociated from FDA and redirected to another more appropriate organization. He pointed out that HHS and FDA have failed to support the RHAC efforts, as exemplified by the poor handling of meetings and the failure to conduct meetings under the Sunshine Law (open to public). He suggested that this suggests a lack of organizational commitment to the RH project. He recommended (a) press releases/notifications regarding availability of data, (b) web site postings of committee meetings well in advance of the meeting dates, (c) notices sent to VSO's, (d) spot-lighting of committee activities in order to call attention to it, and (e) conducting meetings at an alternative (Washington, DC proper) location.
- Future meeting: Spring 2002 meeting at Scripts in CA.
- Transcript: Additional specific details of the discussion points, SOW issues, study considerations, committee recommendations, action items, and public comments summarized in these minutes are available at length in the meeting transcript.
____________/s/_____________________ 06/08/01
Robert W. Harrison, M.D. Date
Chair, Ranch Hand Advisory Committee
___________/s/______________________ 06/08/01
Leonard M. Schechtman, Ph.D. Date
Executive Secretary